A detailed history of Susquehanna International Group, LLP transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 190,455 shares of LUCD stock, worth $236,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190,455
Holding current value
$236,164
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$0.79 - $1.59 $150,459 - $302,823
190,455 New
190,455 $283,000
Q1 2022

May 16, 2022

SELL
$2.85 - $5.24 $37,776 - $69,456
-13,255 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.87 - $11.76 $64,551 - $155,878
13,255 New
13,255 $71,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $47.8M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.